• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两性霉素 B、环丙沙星和多形核白细胞三联组合对烟曲霉的协同作用。

Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus.

机构信息

3rd Department of Pediatrics, Hippokration Hospital, Konstantinoupoleos 49, GR-546 42 Thessaloniki, Greece.

出版信息

Antimicrob Agents Chemother. 2011 Dec;55(12):5923-9. doi: 10.1128/AAC.00548-11. Epub 2011 Sep 12.

DOI:10.1128/AAC.00548-11
PMID:21911564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3232811/
Abstract

Aspergillus is damaged by polymorphonuclear neutrophils (PMNs) by means of nonoxidative and oxidative mechanisms, which may be affected by antifungal and antibacterial agents that patients with invasive pulmonary aspergillosis often receive. The pharmacodynamic interactions among deoxycholate amphotericin B (AMB), ciprofloxacin (CIP), and human PMNs against Aspergillus fumigatus growth are unknown. We therefore studied the interactions between 0.032 to 2.0 μg/ml of AMB, 0.1 to 50 μg/ml of CIP at a fixed AMB/CIP ratio of 1:3.125, and PMNs from six donors at an effector-to-target (E:T) ratio of 400:1 against a clinical A. fumigatus isolate using an XTT metabolic assay and the Bliss independence pharmacodynamic-interaction model. CIP exhibited no antifungal activity alone or in combination with PMNs. Synergy was found between AMB and PMNs, with interaction indices (II) of 0.06 to 0.21; the highest interaction of 21% ± 3.6% was observed at 0.22 ± 0.09 μg/ml of AMB. The AMB and CIP (AMB+CIP) combination was synergistic (II = 0.39) at low AMB concentrations and antagonistic (II = 1.39) at high AMB concentrations, with a maximal synergistic interaction of 16% ± 3.7% observed at 0.16 ± 0.08 μg/ml of AMB. The triple combination AMB+CIP+PMNs was synergistic, with interaction indices of 0.05 to 0.20, and a maximal synergistic interaction of 24% ± 4% was observed at 0.20 ± 0.07 μg/ml of AMB. The increased percentage of Bliss synergy of the triple combination AMB+CIP+PMNs (24% ± 4%) was the product of those of the constituent double combinations AMB+PMNs (21% ± 3.6%) and AMB+CIP (16% ± 3.7%). Thus, the antifungal activity of AMB, at clinically relevant concentrations, was enhanced in combination with PMNs and CIP against A. fumigatus growth in a concentration-dependent manner.

摘要

曲霉属被多形核中性粒细胞(PMN)通过非氧化和氧化机制所破坏,这一过程可能受到侵袭性肺曲霉病患者常接受的抗真菌和抗菌药物的影响。脱氧胆酸盐两性霉素 B(AMB)、环丙沙星(CIP)和人 PMN 对烟曲霉生长的药效学相互作用尚不清楚。因此,我们研究了 0.032 至 2.0μg/ml 的 AMB、0.1 至 50μg/ml 的 CIP 在固定 AMB/CIP 比为 1:3.125 以及 6 位供体的 PMN 与临床烟曲霉分离株的效应器与靶标(E:T)比为 400:1 时的相互作用,使用 XTT 代谢测定法和 Bliss 独立性药效学相互作用模型。CIP 单独或与 PMN 联合使用时均无抗真菌活性。AMB 和 PMN 之间存在协同作用,相互作用指数(II)为 0.06 至 0.21;在 0.22±0.09μg/ml 的 AMB 时观察到最高的 21%±3.6%的相互作用。AMB 和 CIP(AMB+CIP)组合在低 AMB 浓度时协同(II=0.39),在高 AMB 浓度时拮抗(II=1.39),在 0.16±0.08μg/ml 的 AMB 时观察到最大协同作用 16%±3.7%。AMB+CIP+PMN 的三联组合具有协同作用,相互作用指数为 0.05 至 0.20,在 0.20±0.07μg/ml 的 AMB 时观察到最大协同作用 24%±4%。三联组合 AMB+CIP+PMN 的 Bliss 协同作用增加百分比(24%±4%)是其组成的双重组合 AMB+PMN(21%±3.6%)和 AMB+CIP(16%±3.7%)的产物。因此,在临床相关浓度下,AMB 的抗真菌活性与 PMN 和 CIP 联合使用时,以浓度依赖性方式增强了对烟曲霉生长的抑制作用。

相似文献

1
Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus.两性霉素 B、环丙沙星和多形核白细胞三联组合对烟曲霉的协同作用。
Antimicrob Agents Chemother. 2011 Dec;55(12):5923-9. doi: 10.1128/AAC.00548-11. Epub 2011 Sep 12.
2
Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus.基于自身药物相加组合、蒙特卡罗模拟分析和抗烟曲霉药物组合的体外-体内相关性数据,定义抗真菌药物组合对抗烟曲霉的相加相互作用的分数抑制浓度指数截断值。
Antimicrob Agents Chemother. 2010 Feb;54(2):602-9. doi: 10.1128/AAC.00999-09. Epub 2009 Dec 7.
3
In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods.不同方法测定海藻糖裂合酶与两性霉素 B 对烟曲霉生物膜体外相互作用。
Antimicrob Agents Chemother. 2013 Mar;57(3):1275-82. doi: 10.1128/AAC.01875-12. Epub 2012 Dec 21.
4
Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp.棘白菌素类药物(卡泊芬净和米卡芬净)与唑类药物(伏立康唑和泊沙康唑)联合应用治疗侵袭性曲霉病的临床研究进展
Mycoses. 2010 May;53(3):239-45. doi: 10.1111/j.1439-0507.2009.01700.x. Epub 2009 Mar 7.
5
Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.环丙沙星、莫西沙星和左氧氟沙星与抗真菌剂对白色念珠菌和烟曲霉的比较药效学相互作用分析。
J Antimicrob Chemother. 2009 Feb;63(2):343-8. doi: 10.1093/jac/dkn473. Epub 2008 Dec 24.
6
Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus.抗真菌药物与环丙沙星对白色念珠菌和烟曲霉药效学相互作用的等高线图分析
Antimicrob Agents Chemother. 2008 Jun;52(6):2196-204. doi: 10.1128/AAC.00735-07. Epub 2008 Feb 25.
7
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.三联抗真菌药物组合对曲霉菌种的浓度依赖性协同和拮抗作用:采用新的响应面模型进行分析
Antimicrob Agents Chemother. 2007 Jun;51(6):2053-64. doi: 10.1128/AAC.00873-06. Epub 2007 Mar 26.
8
Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.去糖整合素-1 靶向抗真菌脂质体显示出增强的疗效。
mSphere. 2019 Feb 13;4(1):e00025-19. doi: 10.1128/mSphere.00025-19.
9
and Exposure-Effect Relationship of Liposomal Amphotericin B against Aspergillus fumigatus.脂质体两性霉素 B 对烟曲霉的暴露-效应关系。
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.02673-18. Print 2019 Jun.
10
[The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].[棓丙酯对多种抗真菌药物体外抗丝状真菌活性的影响]
Zhonghua Yan Ke Za Zhi. 2006 Apr;42(4):309-12.

引用本文的文献

1
Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects.新一代抗真菌药物:作用机制、疗效及临床前景。
Acta Pharm Sin B. 2025 Aug;15(8):3852-3887. doi: 10.1016/j.apsb.2025.06.013. Epub 2025 Jun 23.
2
Hidden suppressive interactions are common in higher-order drug combinations.隐藏的抑制性相互作用在高阶药物组合中很常见。
iScience. 2021 Mar 26;24(4):102355. doi: 10.1016/j.isci.2021.102355. eCollection 2021 Apr 23.
3
Resistance mechanism and proteins in species against antifungal agents.物种中对抗真菌剂的抗性机制和蛋白质。
Mycology. 2019 Feb 6;10(3):151-165. doi: 10.1080/21501203.2019.1574927. eCollection 2019.
4
Viscosin-like lipopeptides from frog skin bacteria inhibit Aspergillus fumigatus and Batrachochytrium dendrobatidis detected by imaging mass spectrometry and molecular networking.蛙皮细菌来源的几丁质结合脂肽类物质通过成像质谱和分子网络检测抑制烟曲霉和蛙壶菌。
Sci Rep. 2019 Feb 28;9(1):3019. doi: 10.1038/s41598-019-39583-7.
5
Impact of Antifungal Compounds on Viability and Anti- Activity of Human Natural Killer Cells.抗真菌化合物对人自然杀伤细胞活力和抗活性的影响。
Antimicrob Agents Chemother. 2019 Jan 29;63(2). doi: 10.1128/AAC.01993-18. Print 2019 Feb.
6
Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?为治疗细菌感染而优化的氟喹诺酮类药物的抗病毒、抗真菌和抗寄生虫活性:是一个令人困惑的悖论还是其作用方式的必然结果?
Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):661-8. doi: 10.1007/s10096-014-2296-3. Epub 2014 Dec 17.
7
Chitosan sponges for local synergistic infection therapy: a pilot study.壳聚糖海绵用于局部协同抗感染治疗:一项初步研究。
Clin Orthop Relat Res. 2013 Oct;471(10):3158-64. doi: 10.1007/s11999-013-2988-5. Epub 2013 Apr 20.

本文引用的文献

1
Epidemiology of invasive fungal infections in neonates and children.新生儿和儿童侵袭性真菌感染的流行病学。
Clin Microbiol Infect. 2010 Sep;16(9):1321-7. doi: 10.1111/j.1469-0691.2010.03288.x.
2
Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus.两性霉素 B 制剂诱导人单核细胞对烟曲霉菌丝反应的差异转录谱。
Med Mycol. 2011 Feb;49(2):176-85. doi: 10.3109/13693786.2010.510539. Epub 2010 Aug 31.
3
Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention.儿科重症监护病房患者念珠菌血症的危险因素和预测因素:预防意义。
Clin Infect Dis. 2010 Sep 1;51(5):e38-45. doi: 10.1086/655698.
4
Interaction of phagocytes with filamentous fungi.吞噬细胞与丝状真菌的相互作用。
Curr Opin Microbiol. 2010 Aug;13(4):409-15. doi: 10.1016/j.mib.2010.04.009. Epub 2010 Jun 2.
5
Aspergillosis.曲霉病
N Engl J Med. 2009 Apr 30;360(18):1870-84. doi: 10.1056/NEJMra0808853.
6
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.联合治疗实验性肺曲霉病:通过布利斯独立性药物相互作用分析研究阿尼芬净与伏立康唑浓度和剂量依赖性相互作用的体外和体内相关性
Antimicrob Agents Chemother. 2009 Jun;53(6):2382-91. doi: 10.1128/AAC.00329-09. Epub 2009 Mar 23.
7
Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.环丙沙星、莫西沙星和左氧氟沙星与抗真菌剂对白色念珠菌和烟曲霉的比较药效学相互作用分析。
J Antimicrob Chemother. 2009 Feb;63(2):343-8. doi: 10.1093/jac/dkn473. Epub 2008 Dec 24.
8
Antibiotics for the prevention of febrile neutropenia.用于预防发热性中性粒细胞减少症的抗生素。
Curr Opin Hematol. 2009 Jan;16(1):48-52. doi: 10.1097/MOH.0b013e32831ac543.
9
Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study.危重症患者的环丙沙星药代动力学:一项前瞻性队列研究。
J Crit Care. 2008 Sep;23(3):422-30. doi: 10.1016/j.jcrc.2007.11.011. Epub 2008 Apr 18.
10
Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus.抗真菌药物与环丙沙星对白色念珠菌和烟曲霉药效学相互作用的等高线图分析
Antimicrob Agents Chemother. 2008 Jun;52(6):2196-204. doi: 10.1128/AAC.00735-07. Epub 2008 Feb 25.